pyrazinamide has been researched along with Latent Tuberculosis in 14 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 10-year-old child treated for latent tuberculosis infection (LTBI) with pyrazinamide (PZA) and levofloxacin after contact with a smear-positive multidrug-resistant tuberculosis adult." | 3.91 | Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin. ( Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C, 2019) |
| "Treatment of latent tuberculosis infection (LTBI) is an important component of tuberculosis (TB) control, and this study updates a previous network meta-analysis of the best LTBI treatment options to inform public health action and programmatic management of LTBI." | 2.55 | Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. ( Beer, N; Harris, RJ; Lipman, MC; Stagg, HR; van der Werf, MJ; Zenner, D, 2017) |
| "Effective treatment of latent tuberculosis infection (LTBI) is an important component of TB elimination programs." | 2.50 | Treatment of latent tuberculosis infection: a network meta-analysis. ( Abubakar, I; Harris, RJ; Lipman, MC; Muñoz, L; Stagg, HR; Zenner, D, 2014) |
| "The uveitis was treated with local and systemic anti-inflammatory and immunosuppressive therapy in all patients." | 1.48 | Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis. ( Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X, 2018) |
| "This thioridazine exposure was calculated to extinguish all three M." | 1.39 | Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners. ( Gumbo, T; Leff, R; Meek, C; Musuka, S; Pasipanodya, J; Siyambalapitiyage Dona, CW; Srivastava, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (92.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hartman-Adams, H | 1 |
| Gerbo, RM | 1 |
| George, S | 1 |
| Khan, MT | 1 |
| Kaushik, AC | 1 |
| Bhatti, AI | 1 |
| Zhang, YJ | 1 |
| Zhang, S | 1 |
| Wei, AJ | 1 |
| Malik, SI | 1 |
| Wei, DQ | 1 |
| Marks, SM | 1 |
| Mase, SR | 1 |
| Morris, SB | 1 |
| Zenner, D | 2 |
| Beer, N | 1 |
| Harris, RJ | 2 |
| Lipman, MC | 2 |
| Stagg, HR | 2 |
| van der Werf, MJ | 1 |
| Tomkins-Netzer, O | 1 |
| Leong, BCS | 1 |
| Zhang, X | 1 |
| Lightman, S | 1 |
| McCluskey, PJ | 1 |
| Huguet, A | 1 |
| Ader, F | 1 |
| Ohlmann, C | 1 |
| Collardeau-Frachon, S | 1 |
| Gillet, Y | 1 |
| Musuka, S | 1 |
| Srivastava, S | 1 |
| Siyambalapitiyage Dona, CW | 1 |
| Meek, C | 1 |
| Leff, R | 1 |
| Pasipanodya, J | 1 |
| Gumbo, T | 1 |
| Adler-Shohet, FC | 1 |
| Low, J | 1 |
| Carson, M | 1 |
| Girma, H | 1 |
| Singh, J | 1 |
| Kumar, N | 1 |
| Kedarisetty, CK | 1 |
| Kumar, S | 1 |
| Khillan, V | 1 |
| Sarin, SK | 1 |
| Muñoz, L | 1 |
| Abubakar, I | 1 |
| Furukawa, NW | 1 |
| Haider, MZ | 1 |
| Allen, SJ | 1 |
| Carlson, SL | 1 |
| Lindquist, SW | 1 |
| Leung, CC | 1 |
| Rieder, HL | 1 |
| Lange, C | 1 |
| Yew, WW | 1 |
| Duarte, R | 1 |
| Carvalho, A | 1 |
| Correia, A | 1 |
| Lytras, T | 1 |
| Spala, G | 1 |
| Bonovas, S | 1 |
| Panagiotopoulos, T | 1 |
6 reviews available for pyrazinamide and Latent Tuberculosis
| Article | Year |
|---|---|
Marine Natural Products and Drug Resistance in Latent Tuberculosis.
Topics: Antitubercular Agents; Biological Products; Drug Resistance; Humans; Latent Tuberculosis; Microbial | 2019 |
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacter | 2017 |
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Combinations; Huma | 2017 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; L | 2014 |
Treatment of latent tuberculosis infection: a network meta-analysis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Th | 2014 |
Treatment of latent infection with Mycobacterium tuberculosis: update 2010.
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Communicable Disease Control; Drug | 2011 |
8 other studies available for pyrazinamide and Latent Tuberculosis
| Article | Year |
|---|---|
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; T | 2022 |
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; | 2018 |
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; | 2019 |
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
Topics: Antipsychotic Agents; Antitubercular Agents; Colony Count, Microbial; Computer Simulation; Drug Admi | 2013 |
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.
Topics: Adolescent; Antibiotic Prophylaxis; Antitubercular Agents; Child; Contact Tracing; Humans; Latent Tu | 2014 |
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Res | 2017 |
Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female | 2012 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tub | 2012 |